SUPHANNEE LIMPRATHAN: Open Payments
NPI 1487205225 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,503 in 37 payments from 14 companies in 2025. Trend: 2023 $760 · 2024 $796 · 2025 $1,503
Food & beverage: $999Education: $505
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $529 |
| Incyte Corporation | 2 | $225 |
| Lilly USA, LLC | 2 | $206 |
| Alexion Pharmaceuticals, Inc. | 1 | $100 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Celgene Corporation | 2 | $62 |
| GlaxoSmithKline, LLC. | 2 | $57 |
| Geron Corporation | 2 | $52 |
| SOBI, INC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $35 |
Products named: VERZENIO, CARVYKTI, TALVEY, RYBREVANT, Niktimvo, DARZALEX, SOLIRIS, Vanflyta.
Industry payments across CA — which companies pay providers there.
